Your browser doesn't support javascript.
loading
Pharmacokinetics of 2,000 Milligram Ertapenem in Tuberculosis Patients.
Zuur, M A; Ghimire, S; Bolhuis, M S; Wessels, A M A; van Altena, R; de Lange, W C M; Kosterink, J G W; Touw, D J; van der Werf, T S; Akkerman, O W; Alffenaar, J W C.
Afiliação
  • Zuur MA; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Ghimire S; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Bolhuis MS; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Wessels AMA; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • van Altena R; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • de Lange WCM; University of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands.
  • Kosterink JGW; University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
  • Touw DJ; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • van der Werf TS; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, The Netherlands.
  • Akkerman OW; University of Groningen, University Medical Center Groningen, Department of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
  • Alffenaar JWC; University of Groningen, Groningen Research Institute of Pharmacy, Section Pharmacokinetics, Toxicology and Targeting, Groningen, The Netherlands.
Antimicrob Agents Chemother ; 62(5)2018 05.
Article em En | MEDLINE | ID: mdl-29439978
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose / Ertapenem / Antituberculosos Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose / Ertapenem / Antituberculosos Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda